AKT1 and Parkinson disease: Higher doses of oleuropein demonstrated a neuroprotective effect against rotenone-induced Parkinson’s disease (PD), effectively restoring the BDNF/CREB/Akt pathway, reducing apoptotic markers, and improving motor performance (Table 5).